Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin

International Journal of Antimicrobial Agents

Volumn 35, Issue 5, 2010, Pages 497-499

  Falagas, Matthew E ^a,b,c   Maraki, Sofia ^d   Karageorgopoulos, Drosos E ^a   Kastoris, Antonia C ^a   Kapaskelis, Anastasios ^a,c   Samonis, George ^d  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY DUNANT HOSPITAL   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Antimicrobials; Infections; Staphylococcus aureus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISK DIFFUSION; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ENTEROCOCCUS; FOSFOMYCIN; GRAM-POSITIVE BACTERIAL INFECTIONS; GREECE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 77949654111     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.01.010     Document Type: Article

References (15)

1. Levy S.B., Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004, 10(12 Suppl.):S122-S129.
2. Arias C.A., Murray B.E. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 2009, 360:439-443.
3. Karageorgopoulos D.E., Falagas M.E. New antibiotics: optimal use in current clinical practice. Int J Antimicrob Agents 2009, 34(Suppl. 4):S55-S62.
4. Falagas M.E., Giannopoulou K.P., Kokolakis G.N., Rafailidis P.I. Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis 2008, 46:1069-1077.
5. Reeves D.S. Fosfomycin trometamol. J Antimicrob Chemother 1994, 34:853-858.
6. Thomson R.B. Specimen collection, transport and processing: bacteriology. Manual of clinical microbiology 2007, vol. 1:291-333. American Society for Microbiology, Washington, DC. 9th ed.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI, 2007.
8. Falagas M.E., Roussos N., Gkegkes I.D., Rafailidis P.I., Karageorgopoulos D.E. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin Investig Drugs 2009, 18:921-944.
9. Barakett V., Lesage D., Delisle F., Burghoffer B., Richard G., Vergez P., et al. Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci. J Antimicrob Chemother 1993, 31:105-109.
10. Georgopapadakou N.H., Liu F.Y. Binding of β-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity. Antimicrob Agents Chemother 1980, 18:834-836.
11. Ellington M.J., Livermore D.M., Pitt T.L., Hall L.M., Woodford N. Mutators among CTX-M β-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance. J Antimicrob Chemother 2006, 58:848-852.
12. Nakaminami H., Noguchi N., Nishijima S., Kurokawa I., Sasatsu M. Characterization of the pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus. Plasmid 2008, 60:108-117.
13. Roussos N., Karageorgopoulos D.E., Samonis G., Falagas M.E. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents 2009, 34:506-515.
14. Diep B.A., Chambers H.F., Graber C.J., Szumowski J.D., Miller L.G., Han L.L., et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008, 148:249-257.
15. Careddu P., Borzani M., Scotti L., Varotto F., Garlaschi L., Fontana P. Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid. Chemioterapia 1987, 6:290-294.